4P 018
Alternative Names: 4P-018Latest Information Update: 11 Aug 2021
Price :
$50 *
At a glance
- Originator 4P-Pharma
- Class Antidementias
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Alzheimer's disease